Osteopathic Manipulative Treatment for Gastro-oesophageal Reflux Disease
Italy30 participantsStarted 2024-02-18
Plain-language summary
To evaluate the effects of osteopathic manipulative treatment in patients affected by symptoms related to gastro-oesophageal reflux disease (GERD)
Who can participate
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Retrosternal burning sensation and/or regurgitation
* Diagnosis of reflux with any methodology
* Duration of symptoms for more than 3 months
* Taking short or long-term proton pump inhibitors (as needed, treatment start date and expected end date, mg, drug name)
* With or without esophagitis
* With or without hiatal hernia
* With or without helicobacter pylori
* GERDQ questionnaire \> 8 points
Exclusion Criteria:
* neoplastic pathologies
* patients who have undergone surgery for GERD
* systemic pathologies (rheumatic, infectious conditions, feverish state, vascular alterations, endocrine diseases including diabetes, metabolic and neoplastic syndromes),
* patients already undergoing manipulative therapy for reflux
* patients with active gastric ulcers
* congenital or acquired immune diseases
* allergic state of any kind
* pregnancy
* use of intrauterine device
* patients undergoing corticosteroid therapy
* patients already subjected to manual/respiratory therapy in the last 3 months
What they're measuring
1
Mean change in GERD-HRQL
Timeframe: At week 2, 4 an 8.
2
Adverse effects
Timeframe: At week 2, 4 and through study completion (8 weeks)